<DOC>
	<DOCNO>NCT00469664</DOCNO>
	<brief_summary>Our overall aim determine administration guanfacine combination aripiprazole , olanzapine , quetiapine , and/or risperidone significantly effective medication alone treat cognitive impairment schizophrenia .</brief_summary>
	<brief_title>Guanfacine Adjunctive Treatment Atypical Antipsychotics Cognitive Dysfunction Schizophrenia</brief_title>
	<detailed_description>The propose study double blind , placebo control , parallel design investigation compare effect one four atypical antipsychotic ( aripiprazole , olanzapine , quetiapine , and/or risperidone ) , treatment alone treatment one addition treatment guanfacine maximum dose 3.0 mg per day cognitive task performance schizophrenic patient . The study take place fourteen week . Patients receive study medication last ten week protocol .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>1 . Subjects males female age 18 55 . 2 . In good general medical health . 3 . Have DSMIV diagnosis schizophrenia , subtype , schizoaffective disorder . 4 . Patients diagnose DSMIV Axis I disorder may include , unless actively use illicit substance . 5 . Receiving treatment aripiprazole , olanzapine , quetiapine , and/or risperidone antipsychotic medication 6 . Subjects demonstrate significant memory impairment perform least two standard deviation normal performance California Verbal Learning Test ( CVLT ) . Using subject clear impairment acquisition recall avoid ceiling effect measure . 7 . Subjects also require least 8th grade read level and/or fullscale IQ least 85 assessed Wide Range Achievement Test ( WRAT ) . 8 . Patients allow follow antidepressant medication : Fluoxetine ( PROZAC ) , Sertraline ( ZOLOFT ) , Paroxetine ( PAXIL ) , Celexa ( CITALOPRAM ) , Busprion ( WELLBUTRIN ) , Venlafaxine ( EFFEXOR ) , Buspirone ( BUSPAR ) . 1 . Have recent history ( within previous year ) serious suicide , homicide , serious physical violence , current suicidal homicidal thought 2 . Active use illicit substance . 3 . Meet DSMIV criterion current episode major depression mania . 4 . Have history severe head trauma , neurological disorder medical illness may contribute patient 's psychiatric symptom cognitive impairment . 5 . Have medical illness require take medication CNS activity know interact guanfacine ( e.g barbiturate , apha1 antagonist , beta blocker ) . 6 . Receive treatment concomitant neuroleptic addition risperidone olanzapine . 7 . Receive concomitant anticholinergic drug , . If patient receives benzodiazepine , must short intermediate acting ( e.g . alprazolam , lorazepam ) must hold 48 hour prior cognitive testing . Treatment mood stabilizer lithium depakote allow study . If patient receive treatment lithium level must &lt; 1 meq/l . 8 . Are unable give inform consent . 9 . Have history developmental disorder less eighth grade read level . 10 . Have history bowel obstruction untreated benign prostatic hypertrophy . Are take antihypertensive medication class betablockers , alpha1 antagonist , calcium channel blocker , alpha2 agonist .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective</keyword>
	<keyword>Cognitive Impairment</keyword>
	<keyword>Cognition</keyword>
	<keyword>Memory</keyword>
	<keyword>Attention</keyword>
	<keyword>Concentration</keyword>
</DOC>